Brvo - branch retinal vein occlusion
Clinical trials for Brvo - branch retinal vein occlusion explained in plain language.
Never miss a new study
Get alerted when new Brvo - branch retinal vein occlusion trials appear
Sign up with your email to follow new studies for Brvo - branch retinal vein occlusion, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New eye injection shows promise for blinding swelling
Disease control CompletedThis early-stage study tests a new drug called EYE201, given as three eye injections over 12 weeks, to see if it is safe and can help reduce swelling in the back of the eye. It includes people with three different eye conditions that cause vision loss: branch retinal vein occlusi…
Matched conditions: BRVO - BRANCH RETINAL VEIN OCCLUSION
Phase 1/2 • Sponsor: EyeBiotech Ltd. • Aim: Disease control
Last updated Aug 26, 2026 00:00 UTC
-
Eye injection aims to tame leading causes of blindness
Disease control CompletedThis study tests the safety of an experimental eye injection called ONS-5010 (bevacizumab) in people with vision loss from wet age-related macular degeneration, diabetic macular edema, or branch retinal vein occlusion. Participants receive the injection and are monitored for side…
Matched conditions: BRVO - BRANCH RETINAL VEIN OCCLUSION
Phase 3 • Sponsor: Outlook Therapeutics, Inc. • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC